Investor Relations

Investor Relations

Corporate Profile

Abaxis manufactures point-of-care blood analyzers which provide clinicians with rapid blood-constituent measurements for both humans and animals. The analyzers are designed to be portable, require minimal training, provide on-the-spot results, and offer built-in quality control and calibration. The analyzers come with the reagent discs required to perform several of the most common... More >>

Recent NewsMore >>
DateTitle 
04/18/14Federal Court Grants Preliminary Approval Of Settlement In Abaxis Shareholder LawsuitPrinter Friendly Version
04/15/14Abaxis To Report Fourth Quarter And Fiscal Year 2014 Financial Results Thursday, April 24, 2014Printer Friendly Version
04/08/14Abaxis Receives Health Canada Class III Approval for Piccolo Xpress®Printer Friendly Version
03/28/14Abaxis Receives CLIA Waiver For Capillary Sampling For Cholesterol, HDL And TriglyceridesPrinter Friendly Version
Contact Information
Primary IR Contact
Abaxis, Inc.
Phone: 510-675-6500
Fax: 510-441-6151
E-mail: investors@abaxis.com

Transfer Agent
Computershare
Providence, RI 
Phone: (877) 282-1169

Accountants
Burr Pilger Mayer, Inc.
San Jose, CA 

Legal
Cooley Godward Kronish LLP
San Francisco, CA 


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

ABAX (Common Stock)
ExchangeNASDAQ
Price39.17
Change Stock is Up 0.56
Volume96,745
04/17/14 4:00 p.m. ET
20 minute delay
Refresh quote

Featured Reports
 
Annual Review 2013
Form 10-K 2013
Download Documentation 10-Q 12/31/2013
Get help downloading or viewing the above file types